Sign in
8-K

Current Report

CytomX Therapeutics, Inc. Filed Acc 0001193125-22-290176

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d402086d8k.htm…